Raed Alroughani

37PUBLICATIONS
121CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersPharmacogenomicsNeurology and neuromuscular diseasesRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|May 29, 2026
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

|Apr 01, 2026
Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.

Andrea Surcinelli, Tomas Kalincik, Izanne Roos

|Apr 01, 2026
Insights into adherence to cladribine tablets in the real world in multiple countries: results from patient support programs.

Jiwon Oh, Mavis Ayer, Raed Alroughani

|Mar 05, 2026
Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder.

Pakeeran Siriratnam, Vilija G Jokubaitis, Anneke Van Der Walt

|Dec 30, 2025
Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase Registry.

Enrique Gomez-Figueroa, Patricia Orozco-Puga, Cynthia Patricia Corona-Vázquez

|Nov 05, 2025
Guiding Multiple Sclerosis Care: An Update to the 2013 Consensus Statement from the MS in the 21st Century Steering Group.

Raed Alroughani, Elisabeth G Celius, Helen Gray

Pageof 7

Frequent Collaborators

14 joint publications

Anneke van der Walt

12 joint publications

Tomas Kalincik

11 joint publications

Francesco Patti

8 joint publications

Dana Horáková